Showing 20,541 - 20,560 results of 107,530 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (nn decrease)) ))', query time: 1.05s Refine Results
  1. 20541

    Binding of PregOBP56a to <i>N</i>-phenyl-1-naphthylamine (1-NPN) and potential ligands derived from chicken meat. by Yuko Ishida (104789)

    Published 2013
    “…F, Binding of PregOBP56a to various ligands at pH 5. The binding affinity of stearic acid decreased to same level as decanoic acid, palmityl acetate, and cholesterol. …”
  2. 20542
  3. 20543
  4. 20544
  5. 20545
  6. 20546

    Domain architecture of DLAR and PTP99A RPTPs. by Lalima L. Madan (205695)

    Published 2011
    “…The numbers in red refer to the amino acid numbering used for the models in the Molecular Dynamics Simulations. (Also listed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0024766#pone.0024766.s010" target="_blank">Table S5</a>) B: Modulatory effects of the catalytically inactive D2 domain on the activity of the D1 domain of DLAR and PTP99A. …”
  7. 20547

    Retinal layer thickness changes in BRAO and CRAO patients. by Thomas R. Shearer (9761486)

    Published 2023
    “…(B) Right eye from a 68-year-old male patient 36 days after celio-retinal artery infarct BRAO with a VA of 20/25 V. …”
  8. 20548
  9. 20549

    Cholesterol Corrects Altered Conformation of MHC-II Protein in <i>Leishmania donovani</i> Infected Macrophages: Implication in Therapy by Koushik Roy (193484)

    Published 2016
    “…<div><p>Background</p><p>Previously we reported that Kala-azar patients show progressive decrease in serum cholesterol as a function of splenic parasite burden. …”
  10. 20550

    Data_sheet_1_Therapeutic effect of psilocybin in addiction: A systematic review.docx by Pim B. van der Meer (9606147)

    Published 2023
    “…In a pilot study (n = 10), the percentage of heavy drinking days decreased significantly between baseline and weeks 5–12 (mean difference of 26.0, 95% CI = 8.7–43.2, p = 0.008). …”
  11. 20551
  12. 20552
  13. 20553

    A novel second-generation platinum derivative and evaluation of its anti-cancer potential by Habibe Yilmaz (4865200)

    Published 2023
    “…While tumor growth was continued in the control group, the tumor volume decreased in the treatment group. All results point to the conclusion that the new compound has the potential to treat solid tumors.…”
  14. 20554

    Increased tumor uptake upon doxorubicin treatment using [<sup>11</sup>C]-AnxA5-ST but not [<sup>11</sup>C]-mTrx-GFP-ST. by Qing Cheng (145897)

    Published 2012
    “…Note the similar uptake of [<sup>11</sup>C]-AnxA5-ST and [<sup>11</sup>C]-mTrx-GFP-ST in untreated mice, due to the non-specific EPR effect, while upon doxorubicin treatment an increase in [<sup>11</sup>C]-AnxA5-ST uptake was seen in contrast to a non-statistically significant tendency to decrease of [<sup>11</sup>C]-mTrx-GFP-ST. …”
  15. 20555
  16. 20556

    Expression of proteins associated with AD is altered by eIF4A inhibition. by Andrew Bottley (361376)

    Published 2013
    “…Significant differences (p≤0.05 by t-test) are indicated by asterisks. <b>C</b>. Secreted A-beta levels in the medium of 9×10<sup>5</sup> SH-SY5Y cells were assayed by ELISA 24 hours following treatment with 10 µM hippuristanol (+), demonstrating a modest but reproducible decrease in comparison to control cells (−). …”
  17. 20557

    Induction of IL-17A production during <i>C. neoformans</i> strain H99γ infection requires IFN-γR expression. by Karen L. Wozniak (229721)

    Published 2011
    “…A. Asterisks (*) indicate where significant decreases in CFU were observed in IFN-γR <sup>−/−</sup> mice compared to wild-type BALB/c mice (<i>P</i><0.01). …”
  18. 20558
  19. 20559

    <i>miR-146a</i> LNA treatment inhibits OSCC oncogenicity. by Pei-Shi Hung (489732)

    Published 2013
    “…(C) <i>miR-146a</i> LNA treatment decreases the growth of SAS cells (Lt) and OECM-1 cells (Rt) with or without exogenous <i>miR-146a</i> expression. …”
  20. 20560